SPECT/CT融合显像在继发性甲状旁腺功能亢进症中的临床价值

doi:10.12117/jccmi.2019.03.005

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the clinical value of dual-phase 99mTc-sestamibi(MIBI) scintigraphy and SPECT/CT imaging in diagnosing secondary hyperparathyroidism. Methods: Retrospectively analyzed the image features of dual-phase 99mTc-MIBI scintigraphy and SPECT/CT of 38 patients with secondary hyperparathyroidism, which were confirmed by postoperative pathology. Results: The sensitivity of 99mTc-MIBI scintigraphy and SPECT/CT in diagnosing secondary hyperthyroidism was 86.52% and 95.74% respectively. There were significant difference between dual-phase 99mTc-MIBI scintigraphy and SPECT/CT. Conclusions: Preoperative 99mTc-MIBI SPECT/CT imaging is significantly better than dual-phase 99mTc-MIBI scintigraphy in evaluating secondary hyperparathyroidism. 99mTc-MIBI SPECT/CT imaging is an ideal examination method for secondary hyperparathyroidism in preoperative location.

Key words： Hyperparathyroidism, secondary Technetium tc 99m sestamibi Tomography, emission-computed, single-photon

Received: 10 April 2018

PACS:	Ｒ582.1
	Ｒ817.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Zheng-guo
	LIU Qi-yu
	WU Chun-yan
	CHEN Jiao
	HE Chuan-dong

Cite this article:

CHEN Zheng-guo,LIU Qi-yu,WU Chun-yan, et al. The diagnostic value of 99mTc-sestamibi SPECT/CT in secondary hyperparathyroidism[J]. JOURNAL OF CHINA MEDICAL IMAGING, 2019, 30(3): 169-173.

URL:

http://www.jccmi.com.cn/EN/10.12117/jccmi.2019.03.005 OR http://www.jccmi.com.cn/EN/Y2019/V30/I3/169

[1]Neyer U, Hoerandner H, Haid A, et al. Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection[J]. Nephrol Dial Transplant, 2002, 17(4): 625-629. [2]Puccinil M, Ceccarelli C, Meniconi O, et al. Near total parathyroidectomy for the treatment of renal hyperparathyroidism[J]. Gland Surg, 2017, 6(6): 638-643. [3]Chen J, Wang JD. Radioguided parathyroidectomy in patients with secondary hyperparathyroidism due to chronic renal failure[J]. Nucl Med Commun, 2014, 35(4): 391-397. [4]Johnson NA, Carty SE, Tublin ME. Parathyroid imaging[J]. Radiol Clin North Am, 2011, 49(3): 489-509. [5]Coakley AJ, Kettle AG, Well CP, et al. 99mTc sestamibi——a new agent for parathyroid imaging[J]. Nucl Med Commun, 1989, 10(11): 791-794. [6]Hetrakul N, Civelek AC, Stagg CA, et al. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria[J]. Surgery, 2001, 130(6): 1011-1018. [7]Moralidis E. Radionuclide parathyroid imaging: a concise, updated review[J]. Hell J Nucl Med, 2013, 16(2): 125-133. [8]Chroustova D, Kubinyi J, Trnka J, et al. The role of 99mTc-MIBI SPECT/CT low dose CT with 3D in subtraction in patients with secondary hyperparathyroidism due to chronic kidney disease[J]. Endocr Regulations, 2014, 48(2): 55-63. [9]Taieb D, Hindie E, Grassetto G, et al. Parathyroid scintigraphy: When, how, and why? A concise systematic review[J]. Clin Nucl Med, 2012, 37(6): 568-574. [10]Burke JF, Naraharisetty K, Schneider DF, et al. Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism[J]. Am J Surg, 2013, 205(3): 269-273. [11]Pons F, Torregrosa JV, Fuster D. Biological factors influencing parathyroid localization[J]. Nucl Med Commun, 2003, 24(2): 121-124. [12]Xue JJ, Liu Y, Yang DR, et al. Dual-phase 99mTc-MIBI imaging and the expressions of P-gp, GST-π, and MRP1 in hyperparathyroidism[J]. Nucl Med Commun, 2017, 38(10): 868-874. [13]Hayakawa N, Nakamoto Y, Kurihara K, et al. A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia[J]. Nucl Med Commun, 2015, 36(1): 53-59. [14]Schachter PP, Issa N, Shimonov M, et al. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy[J]. Arch Surg, 2004, 139(4): 433-437. [15]陈正国，刘启榆，陈娇，等. 99mTc-MIBI核素显像与CT在原发性甲状旁腺功能亢进症中的诊断价值[J]. 中国临床医学影像杂志，2016，27（4）：239-242. [16]Mizamtsidi M, Nastos C, Mastorakos G, et al. Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks[J]. Endocr Connections, 2018, 7(2): R56-R68. [17]Ryhnen EM, Schildt J, Heiskanen I, et al. 99mTechnetium sestamibi-123iodine scintigraphy is more accurate than 99mTechnetium sestamibi alone before surgery for primary hyperparathyroidism[J]. Intern J Mol Imaging, 2015, 2015: 391625. [18]Kluijfhout WP, Pasternak JD, Drake FT, et al. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis[J]. Langenbecks Arch Surg, 2016, 401(7): 925-935. [19]Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for SPECT/CT imaging 1.0[J]. J Nucl Med, 2006, 47(7): 1227-1234. [20]Taieb D, Urena-Torres P, Zanotti-Fregonara P, et al. Parathyroid scintigraphy in renal hyperparathyroidism: the added diagnostic value of SPECT and SPECT/CT[J]. Clin Nucl Med, 2013, 38(8): 630-635. [21]Taubman ML, Goldfarb M, Lew JI. Role of SPECT/CT in the surgical treatment of primary hyperparathyroidism[J]. Int J Mol Imaging, 2011, 2011: 141593. [22]Monzen Y, Tamura A, Okaki H, et al. SPECT/CT fusion in the diagnosis of hyperparathyroidism[J]. Asia Ocean J Nucl Med Biol, 2015, 3(1): 61-65. [23]Serra A, Bolasco P, Satta L, et al. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients[J]. Radiol Med, 2006, 11(7): 999-1008. [24]Phitayakorn R, Mchenry CR. Incidence and location of ectopic abnormal parathyroid glands[J]. Am J Surg, 2006, 191(3): 418-423. [25]Hamidi S, Soltani A, Hedayat A, et al. Primary hyperpara-thyroidism: a review of 177 cases[J]. Med Sci Monit, 2006, 12(2): 86-89.